L Catterton to sell supplements provider Thorne to P&G for $3.8bn
- Colin Watts serves as CEO of Thorne
- The transaction is expected to close in the fourth quarter of 2026
L Catterton has agreed to sell Thorne, a Summerville, South Carolina-based provider of supplements, to The Procter & Gamble Company, for $3.8 billion in cash.
L Catterton invested in Thorne in October 2023.
Marc Magliacano, a managing partner at L Catterton, said, “Our investment in Thorne reflects what L Catterton does best: identifying enduring shifts in consumer behavior and partnering with category-leading brands to help them realize their full potential. As consumers increasingly prioritize proactive, clinically-backed solutions that increase healthspan, we believed Thorne was uniquely positioned to lead the category. We are proud to have partnered with the company during this important chapter in its growth and are confident it is well positioned for all that is ahead.”
Colin Watts serves as CEO of Thorne.
The transaction is expected to close in the fourth quarter of 2026.
Perella Weinberg Partners and Canaccord Genuity LLC acted as financial advisors to Thorne, and Kirkland & Ellis served as legal advisor. Jones Day acted as legal advisor to Procter & Gamble.
